Publicacións en colaboración con investigadores/as de Hospital General Universitario de Valencia (4)

2021

  1. Tocilizumab in Behçet's disease with refractory ocular and/or neurological involvement: response according to different clinical phenotypes

    Clinical and experimental rheumatology, Vol. 39, Núm. 5, pp. 37-42

2019

  1. Anti-IL6-Receptor Tocilizumab in Refractory and Noninfectious Uveitic Cystoid Macular Edema: Multicenter Study of 25 Patients

    American Journal of Ophthalmology, Vol. 200, pp. 85-94

2018

  1. Anti-interleukin 6 receptor tocilizumab in refractory uveitis associated with Behçet's disease: Multicentre retrospective study

    Rheumatology (United Kingdom), Vol. 57, Núm. 5, pp. 856-864

2016

  1. The effect of biologic therapy different from infliximab or adalimumab in patients with refractory uveitis due to Behçet's disease: Results of a multicentre open-label study

    Clinical and Experimental Rheumatology, Vol. 34, pp. 34-40